The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Amicus Therapeutics Inc’s current trading price is -52.02% away from its 52-week high, while its distance from the 52-week low is 10.16%. The stock’s price range for this period has been between $5.51 and $12.65 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.24 million for the day, a number notably lower than the average daily volume of 5.03 million over the last three months.
The present stock price for Amicus Therapeutics Inc (FOLD) is $6.07. In the last trading session, the stock made a considerable jump, reaching $22.0 after an opening price of $6.07. The stock briefly fell to $9.0 before ending the session at $5.91.
Amicus Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $12.65 on 11/06/24, while the lowest price for the same period was registered at $5.51 on 06/25/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Amicus Therapeutics Inc (FOLD) has experienced a quarterly decline of -9.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.87B and boasts a workforce of 499 employees.
Amicus Therapeutics Inc: What Analysts Are Saying
As of right now, 8 analysts are rating Amicus Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.08, with a change in price of -3.00. Similarly, Amicus Therapeutics Inc recorded 4,283,862 in trading volume during the last 100 days, posting a change of -33.08%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for FOLD stands at 2.29. Similarly, the long-term debt-to-equity ratio is also 2.25.
FOLD Stock Stochastic Average
Amicus Therapeutics Inc’s raw stochastic average for the past 50 days is presently 45.90%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 59.89%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 60.25% and 65.36%, respectively.
FOLD Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -41.69% this year. Over the last six months, there has been a stronger performance of -34.24%. The price of FOLD fallen by 0.66% during the last 30 days period. For the last 5-days stocks have slided -5.45%.
